Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by KILOFINALon Mar 04, 2021 8:50am
127 Views
Post# 32713235

Nasal spray market forecast

Nasal spray market forecast https://www.globenewswire.com/news-release/2020/09/03/2088755/0/en/Nasal-Spray-Market-Size-2020-Global-Industry-Share-Analysis-Future-Demand-Growth-Rate-CAGR-6-12-to-Witness-High-Demand-Due-to-Increasing-Cases-of-Allergic-Rhinitis-and-Infections-A.html

Nasal Spray Market Size 2020: Global Industry Share Analysis, Future Demand & Growth Rate (CAGR +6.12%) to Witness High Demand Due to Increasing Cases of Allergic Rhinitis and Infections| ADAPT Pharma, Inc., Sandoz International GmbH, INNOVUS PHARMACEUTICALS, INC



Market Analysis

Nasal spray market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 22.71 billion by 2027 growing at a CAGR of 6.12% in the above-mentioned forecast period. The growing cases of allergic rhinitis and infections will help in driving the growth of the nasal spray market.

Download free Sample Report in Depth Analysis & Access Insightful Study with over 200+ pages, list of tables & figures, profiling 20+ companies @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market

Nasal Spray Market report potentially presents with the numerous insights and business solutions that will help to stay ahead of the competition. This report also covers very important aspect which is competitive intelligence and with these businesses can gain competitive advantage to thrive in the market. By taking into account strategic profiling of key players in the Healthcare IT industry, comprehensively analyzing their core competencies, and their strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions, the Nasal Spray Market report helps businesses improve their strategies to sell goods and services.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT, GET FREE COVID-19 SAMPLE @ https://www.databridgemarketresearch.com/covid-19-impact/global-nasal-spray-market

Top players list covered in the nasal spray market report are:

  • ADAPT Pharma, Inc.,
  • Sandoz International GmbH,
  • INNOVUS PHARMACEUTICALS, INC.,
  • Cipla Inc.,
  • Aurena,
  • J Pharmaceuticals,
  • Bayer AG,
  • St. Renatus,
  • ARIUS FORMULATIONS PVT LTD,
  • Ultratech India Limited,
  • GlaxoSmithKline plc,
  • Egalet Corporation,
  • LEEFORD HEALTHCARE LTD,
  • Aishwarya Group,
  • Mylan N.V.,
  • Pfizer Inc.,
  • Teva Pharmaceutical Industries Ltd.,
  • Catalent, Inc,
  • ALLERGAN,

Access Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-nasal-spray-market
The factors driving the growth of this nasal spray market are:

Improving patient compliance and acceptability: Sometimes people are not able to get relief and comfortability which they want even after getting medicines and treatment. For any kind of nasal allergy, nasal spray is very helpful. These nasal sprays are easy to carry and therefore are quite acceptable by the people. These are also used in winter, so that one can add moisture to other dry nose providing instant relief as compared to the other treatment. Availability of different nasal spray in the market and affordable price of these nasal sprays is another reason why the people are accepting it at a larger scale Effectiveness over other forms of drug delivery: Nasal sprays are very useful as they can treat any condition associated with the nasal. As compared to the other treatments, they can provide the relief faster and help them to decrease stuffiness and breathe easier. These allergies can affect your day to day routine and if not treated on time can cause many other problems. So, these nasal sprays are safe and easy to use and can be suitable for children as well due to which they are highly preferable

<< Previous
Bullboard Posts
Next >>